1. Preemptive clinical pharmacogenetics implementation: current programs in five US medical centers;Dunnenberger,2015
2. The Clinical Pharmacogenetics Implementation Consortium: 10 years later;Relling,2020
3. Preemptive pharmacogenetic testing: exploring the knowledge and perspectives of US payers;Keeling,2019
4. Evaluating the extent of reusability of CYP2C19 genotype data among patients genotyped for antiplatelet therapy selection;Beitelshees,2020
5. Agency for Healthcare Research and Quality. Medical Expenditure Panel Survey (MEPS) 2008-2018. Rockville, MD: Agency for Healthcare Research and Quality. 2020.